Developing a new method for creating stable antibody conjugates
Novel Reagents for Rapid and Stable Thiol-Based Bioconjugations
This study is working on a new way to make medical imaging and therapy using antibody treatments safer and more effective, so patients can get better results with less radiation exposure.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Hunter College NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10640245 on NIH RePORTER |
What this research studies
This research focuses on improving the stability and effectiveness of antibody conjugates used in medical imaging and therapy. The team is developing a new reagent called PODS that allows for more reliable binding to thiols, which are important for creating these conjugates. By optimizing this new method, the researchers aim to enhance the performance of radioimmunoconjugates, making them safer and more effective for patients. This could lead to better imaging results and reduced radiation exposure to healthy tissues.
Who could benefit from this research
Good fit: Ideal candidates for this research would include patients undergoing treatments that involve antibody conjugates, particularly in the context of cancer therapies.
Not a fit: Patients who are not receiving antibody-based therapies or those with conditions unrelated to the use of radioimmunoconjugates may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective treatments for patients requiring antibody-based therapies.
How similar studies have performed: Other research has shown promise in improving bioconjugation methods, but the specific approach using PODS is relatively novel.
Where this research is happening
New York, United States
- Hunter College — New York, United States (Active)
Researchers
- Principal investigator: Zeglis, Brian Matthew — Hunter College
- Study coordinator: Zeglis, Brian Matthew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.